📰 Clinical Development News
Page 105 - Clinical Development News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Clinical Development. Real-time updates on events, politics, business and more.
June 22, 2023
Dublin, June 22, 2023 (GLOBE NEWSWIRE) -- The "Gene Therapy: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's...
June 22, 2023
EQS-News: Imcyse SA / Key word(s): Miscellaneous Imcyse joins CLAIMS, a European Health Initiative Project to Make Data-Driven Precision Medicine a Reality for Patients with Multiple Sclerosis 22.06.2023 / 10:30 CET/CEST The issuer is solely responsible for the content of this announcement. Imcy...
June 22, 2023
A topical formulation for the relief of hemorrhoidal symptoms has produced a meaningful reduction in symptom severity in a phase 2b clinical trial.
June 21, 2023
Evaluating safety and efficacy of combining AB-729, VTP-300, nucleoside analogues and nivolumab WARMINSTER, Pa., June 21, 2023 -- Arbutus Biopharma Corporation , a clinical-stage... | June 21, 2023
June 20, 2023
Singapore for the first time became the most expensive city for goods and services for wealthy people, overtaking Hong Kong, London and New York, according to a report on Tuesday. Cars and essential health insurance in Singapore are 133% and 109% more expensive than the global average, among 12 consumer goods and eight services that reflect the spending patterns of high-net-worth individuals, according to Julius Baer's Global Wealth and Lifestyle report this year, Reuters said.
June 19, 2023
An osteoporosis study has demonstrated a high delivery success rate for a breakthrough technology that converts injections into an oral pill.
June 18, 2023
A proven and effective medication for osteoporosis, which is currently only available as an injection, can be administered orally using a novel "robotic pill," according to a study presented Saturday at ENDO 2023, the Endocrine Society's annual meeting in Chicago, Ill.
June 17, 2023
A proven and effective medication for osteoporosis, which is currently only available as an injection, can be administered orally using a novel "robotic pill," according to a study presented Saturday at ENDO 2023, the Endocrine Societys annual meeting in Chicago, Ill.
June 16, 2023
Today, the National Comprehensive Cancer Network® (NCCN®)-;an alliance of leading cancer centers-;convened a policy summit to examine how geography impacts cancer outcomes.
June 16, 2023
/PRNewswire/ -- The "Chinese Biopharma, Clinical Development, CRO Utilization and Outlook 2023" report has been added to ResearchAndMarkets.coms offering....